Join or Renew Your Membership Join

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Effects of Erythropoietin on Endothelial Progenitor Cells, Frataxin Levels and Oxidative Metabolism in the Skeletal Muscle of Friedreich Ataxia Patients
Movement Disorders
(-)
005
Authors/Disclosures
Wolfgang Nachbauer No disclosure on file
Julia V. Wanschitz, MD (Universitats Klinken Innsbruck) No disclosure on file
Markus Reindl, PhD (Medical University of Innsbruck) The institution of Dr. Reindl has received research support from Euroimmun. The institution of Dr. Reindl has received research support from Roche.
No disclosure on file
Werner Poewe, MD (University Hospital of Neurology) Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Harry B. Coslett, MD, FAAN (Univ of Pennsylvania) No disclosure on file
Donna C. Bergen, MD, FAAN (Rush University Medical Center) No disclosure on file
Sylvia Boesch, MD Dr. Boesch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VICO. Dr. Boesch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for REATA.